We are at the start of another work week and this is what I’m reading to get going:
- Biotech Firm Grail Takes The First Steps In Its Quest For A Blood Test For Cancer
- Diminishing the FDA’s power was my intent: Right-to-try author scolds Scott Gottlieb as agency implements new law
- Genomic test can help avoid chemotherapy in breast cancer patients
- Here’s a closer look at the clinical trials, M&A, cool science and regulations driving the industry this week.
Have a great week and feel free to let me know what you read.
